TrialActa orthopaedica2026

Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial.

Caroline Sköld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.